214 related articles for article (PubMed ID: 27183903)
1. Structure of USP7 catalytic domain and three Ubl-domains reveals a connector α-helix with regulatory role.
Kim RQ; van Dijk WJ; Sixma TK
J Struct Biol; 2016 Jul; 195(1):11-8. PubMed ID: 27183903
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of USP7/HAUSP activation by its C-terminal ubiquitin-like domain and allosteric regulation by GMP-synthetase.
Faesen AC; Dirac AM; Shanmugham A; Ovaa H; Perrakis A; Sixma TK
Mol Cell; 2011 Oct; 44(1):147-59. PubMed ID: 21981925
[TBL] [Abstract][Full Text] [Related]
3. Molecular Understanding of USP7 Substrate Recognition and C-Terminal Activation.
Rougé L; Bainbridge TW; Kwok M; Tong R; Di Lello P; Wertz IE; Maurer T; Ernst JA; Murray J
Structure; 2016 Aug; 24(8):1335-1345. PubMed ID: 27452404
[TBL] [Abstract][Full Text] [Related]
4. Kinetic analysis of multistep USP7 mechanism shows critical role for target protein in activity.
Kim RQ; Geurink PP; Mulder MPC; Fish A; Ekkebus R; El Oualid F; van Dijk WJ; van Dalen D; Ovaa H; van Ingen H; Sixma TK
Nat Commun; 2019 Jan; 10(1):231. PubMed ID: 30651545
[TBL] [Abstract][Full Text] [Related]
5. DNA Polymerase ι Interacts with Both the TRAF-like and UBL1-2 Domains of USP7.
Ashton NW; Valles GJ; Jaiswal N; Bezsonova I; Woodgate R
J Mol Biol; 2021 Jan; 433(2):166733. PubMed ID: 33279577
[TBL] [Abstract][Full Text] [Related]
6. The role of UBL domains in ubiquitin-specific proteases.
Faesen AC; Luna-Vargas MP; Sixma TK
Biochem Soc Trans; 2012 Jun; 40(3):539-45. PubMed ID: 22616864
[TBL] [Abstract][Full Text] [Related]
7. Crystal Structure of USP7 Ubiquitin-like Domains with an ICP0 Peptide Reveals a Novel Mechanism Used by Viral and Cellular Proteins to Target USP7.
Pfoh R; Lacdao IK; Georges AA; Capar A; Zheng H; Frappier L; Saridakis V
PLoS Pathog; 2015 Jun; 11(6):e1004950. PubMed ID: 26046769
[TBL] [Abstract][Full Text] [Related]
8. The deubiquitinase USP7 uses a distinct ubiquitin-like domain to deubiquitinate NF-ĸB subunits.
Mitxitorena I; Somma D; Mitchell JP; Lepistö M; Tyrchan C; Smith EL; Kiely PA; Walden H; Keeshan K; Carmody RJ
J Biol Chem; 2020 Aug; 295(33):11754-11763. PubMed ID: 32587091
[TBL] [Abstract][Full Text] [Related]
9. Current and future directions of USP7 interactome in cancer study.
Park HB; Baek KH
Biochim Biophys Acta Rev Cancer; 2023 Nov; 1878(6):188992. PubMed ID: 37775071
[TBL] [Abstract][Full Text] [Related]
10. An Allosteric Interaction Links USP7 to Deubiquitination and Chromatin Targeting of UHRF1.
Zhang ZM; Rothbart SB; Allison DF; Cai Q; Harrison JS; Li L; Wang Y; Strahl BD; Wang GG; Song J
Cell Rep; 2015 Sep; 12(9):1400-6. PubMed ID: 26299963
[TBL] [Abstract][Full Text] [Related]
11. Selectively Modulating Conformational States of USP7 Catalytic Domain for Activation.
Özen A; Rougé L; Bashore C; Hearn BR; Skelton NJ; Dueber EC
Structure; 2018 Jan; 26(1):72-84.e7. PubMed ID: 29249604
[TBL] [Abstract][Full Text] [Related]
12. Regulation of USP7: A High Incidence of E3 Complexes.
Kim RQ; Sixma TK
J Mol Biol; 2017 Nov; 429(22):3395-3408. PubMed ID: 28591556
[TBL] [Abstract][Full Text] [Related]
13. Identification of Kaposi Sarcoma Herpesvirus (KSHV) vIRF1 Protein as a Novel Interaction Partner of Human Deubiquitinase USP7.
Chavoshi S; Egorova O; Lacdao IK; Farhadi S; Sheng Y; Saridakis V
J Biol Chem; 2016 Mar; 291(12):6281-91. PubMed ID: 26786098
[TBL] [Abstract][Full Text] [Related]
14. USP7-Specific Inhibitors Target and Modify the Enzyme's Active Site via Distinct Chemical Mechanisms.
Pozhidaeva A; Valles G; Wang F; Wu J; Sterner DE; Nguyen P; Weinstock J; Kumar KGS; Kanyo J; Wright D; Bezsonova I
Cell Chem Biol; 2017 Dec; 24(12):1501-1512.e5. PubMed ID: 29056420
[TBL] [Abstract][Full Text] [Related]
15. USP7 as an emerging therapeutic target: A key regulator of protein homeostasis.
Guo NJ; Wang B; Zhang Y; Kang HQ; Nie HQ; Feng MK; Zhang XY; Zhao LJ; Wang N; Liu HM; Zheng YC; Li W; Gao Y
Int J Biol Macromol; 2024 Apr; 263(Pt 1):130309. PubMed ID: 38382779
[TBL] [Abstract][Full Text] [Related]
16. Structure-Guided Development of a Potent and Selective Non-covalent Active-Site Inhibitor of USP7.
Lamberto I; Liu X; Seo HS; Schauer NJ; Iacob RE; Hu W; Das D; Mikhailova T; Weisberg EL; Engen JR; Anderson KC; Chauhan D; Dhe-Paganon S; Buhrlage SJ
Cell Chem Biol; 2017 Dec; 24(12):1490-1500.e11. PubMed ID: 29056421
[TBL] [Abstract][Full Text] [Related]
17. Ubiquitin-specific peptidase 7 (USP7) and USP10 mediate deubiquitination of human NHE3 regulating its expression and activity.
Han Y; Yun CC
FASEB J; 2020 Dec; 34(12):16476-16488. PubMed ID: 33095475
[TBL] [Abstract][Full Text] [Related]
18. Backbone and ILV side-chain NMR resonance assignments of the catalytic domain of human deubiquitinating enzyme USP7.
Valles G; Pozhidaeva A; Korzhnev DM; Bezsonova I
Biomol NMR Assign; 2022 Oct; 16(2):197-203. PubMed ID: 35536398
[TBL] [Abstract][Full Text] [Related]
19. USP7: Novel Drug Target in Cancer Therapy.
Wang Z; Kang W; You Y; Pang J; Ren H; Suo Z; Liu H; Zheng Y
Front Pharmacol; 2019; 10():427. PubMed ID: 31114498
[TBL] [Abstract][Full Text] [Related]
20. Elastic network models and molecular dynamic simulations reveal the molecular basis of allosteric regulation in ubiquitin-specific protease 7 (USP7).
Xu J; Wang Y; Zhang J; Abdelmoneim AA; Liang Z; Wang L; Jin J; Dai Q; Ye F
Comput Biol Med; 2023 Aug; 162():107068. PubMed ID: 37290391
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
